Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for BARHL2
Z-value: 1.34
Motif logo
Transcription factors associated with BARHL2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BARHL2
|
ENSG00000143032.7 | BarH like homeobox 2 |
Activity profile of BARHL2 motif
Sorted Z-values of BARHL2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_208031943 | 6.14 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr5_+_31193847 | 6.11 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
| chr4_+_69313145 | 5.72 |
ENST00000305363.4
|
TMPRSS11E
|
transmembrane protease, serine 11E |
| chr18_+_29027696 | 5.55 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
| chr6_+_151646800 | 5.42 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr18_+_21529811 | 4.75 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
| chr12_-_89746173 | 4.70 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
| chr12_+_107712173 | 4.63 |
ENST00000280758.5
ENST00000420571.2 |
BTBD11
|
BTB (POZ) domain containing 11 |
| chr16_-_46655538 | 4.56 |
ENST00000303383.3
|
SHCBP1
|
SHC SH2-domain binding protein 1 |
| chr17_-_38859996 | 4.48 |
ENST00000264651.2
|
KRT24
|
keratin 24 |
| chr12_-_25055177 | 4.44 |
ENST00000538118.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr5_-_146781153 | 4.23 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr17_+_70117153 | 4.22 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
| chr19_-_43382142 | 4.15 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
| chr2_-_238322800 | 4.01 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
| chrX_+_135252050 | 3.80 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
| chrX_+_135251783 | 3.78 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
| chr18_+_34124507 | 3.77 |
ENST00000591635.1
|
FHOD3
|
formin homology 2 domain containing 3 |
| chr2_+_158114051 | 3.69 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
| chr16_+_50300427 | 3.67 |
ENST00000394697.2
ENST00000566433.2 ENST00000538642.1 |
ADCY7
|
adenylate cyclase 7 |
| chr6_+_34204642 | 3.55 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr2_-_238323007 | 3.51 |
ENST00000295550.4
|
COL6A3
|
collagen, type VI, alpha 3 |
| chrX_+_135251835 | 3.51 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
| chr4_+_169013666 | 3.32 |
ENST00000359299.3
|
ANXA10
|
annexin A10 |
| chrX_-_153602991 | 3.29 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
| chr2_-_238322770 | 3.29 |
ENST00000472056.1
|
COL6A3
|
collagen, type VI, alpha 3 |
| chr4_-_143227088 | 3.29 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
| chr7_+_107224364 | 3.27 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
| chr5_-_139726181 | 3.20 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr7_-_25019760 | 3.07 |
ENST00000352860.1
ENST00000353930.1 ENST00000431825.2 ENST00000313367.2 |
OSBPL3
|
oxysterol binding protein-like 3 |
| chr16_+_8806800 | 3.07 |
ENST00000561870.1
ENST00000396600.2 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr12_-_10978957 | 3.03 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
| chr1_+_203651937 | 2.76 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr18_+_21452964 | 2.71 |
ENST00000587184.1
|
LAMA3
|
laminin, alpha 3 |
| chr11_+_35201826 | 2.62 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr8_-_49833978 | 2.56 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
| chr17_-_57229155 | 2.50 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
| chr1_-_152386732 | 2.49 |
ENST00000271835.3
|
CRNN
|
cornulin |
| chr9_+_5450503 | 2.43 |
ENST00000381573.4
ENST00000381577.3 |
CD274
|
CD274 molecule |
| chr11_+_33061543 | 2.41 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
| chr5_+_162887556 | 2.40 |
ENST00000393915.4
ENST00000432118.2 ENST00000358715.3 |
HMMR
|
hyaluronan-mediated motility receptor (RHAMM) |
| chr18_+_21452804 | 2.36 |
ENST00000269217.6
|
LAMA3
|
laminin, alpha 3 |
| chr1_+_152974218 | 2.35 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
| chr14_+_32798547 | 2.33 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr8_+_22424551 | 2.32 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
| chr12_+_110011571 | 2.31 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
| chr5_+_150639360 | 2.27 |
ENST00000523004.1
|
GM2A
|
GM2 ganglioside activator |
| chr14_+_68086515 | 2.21 |
ENST00000261783.3
|
ARG2
|
arginase 2 |
| chr9_+_132099158 | 2.18 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
| chr6_-_131384347 | 2.17 |
ENST00000530481.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr2_-_188419078 | 2.15 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| chr8_-_49834299 | 2.14 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
| chr12_-_91505608 | 2.13 |
ENST00000266718.4
|
LUM
|
lumican |
| chr11_+_64018955 | 2.12 |
ENST00000279230.6
ENST00000540288.1 ENST00000325234.5 |
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific) |
| chr14_+_73706308 | 2.11 |
ENST00000554301.1
ENST00000555445.1 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
| chr18_-_67873078 | 2.11 |
ENST00000255674.6
|
RTTN
|
rotatin |
| chr1_+_84630053 | 2.11 |
ENST00000394838.2
ENST00000370682.3 ENST00000432111.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
| chr19_-_44285401 | 2.10 |
ENST00000262888.3
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| chrX_-_71351678 | 2.10 |
ENST00000609883.1
ENST00000545866.1 |
RGAG4
|
retrotransposon gag domain containing 4 |
| chr8_-_125486755 | 2.09 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
| chr12_-_95510743 | 2.06 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
| chr3_+_156799587 | 2.05 |
ENST00000469196.1
|
RP11-6F2.5
|
RP11-6F2.5 |
| chr19_+_41257084 | 2.04 |
ENST00000601393.1
|
SNRPA
|
small nuclear ribonucleoprotein polypeptide A |
| chr4_+_106631966 | 2.01 |
ENST00000360505.5
ENST00000510865.1 ENST00000509336.1 |
GSTCD
|
glutathione S-transferase, C-terminal domain containing |
| chr9_-_95640218 | 2.00 |
ENST00000395506.3
ENST00000375495.3 ENST00000332591.6 |
ZNF484
|
zinc finger protein 484 |
| chr14_+_32798462 | 1.97 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr8_-_62559366 | 1.96 |
ENST00000522919.1
|
ASPH
|
aspartate beta-hydroxylase |
| chr12_+_15699286 | 1.94 |
ENST00000442921.2
ENST00000542557.1 ENST00000445537.2 ENST00000544244.1 |
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
| chr18_+_56530136 | 1.93 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
| chr3_+_130569429 | 1.91 |
ENST00000505330.1
ENST00000504381.1 ENST00000507488.2 ENST00000393221.4 |
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
| chr1_-_110933611 | 1.89 |
ENST00000472422.2
ENST00000437429.2 |
SLC16A4
|
solute carrier family 16, member 4 |
| chr14_-_91720224 | 1.89 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr4_-_159956333 | 1.87 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
| chr1_-_110933663 | 1.86 |
ENST00000369781.4
ENST00000541986.1 ENST00000369779.4 |
SLC16A4
|
solute carrier family 16, member 4 |
| chr2_+_102456277 | 1.86 |
ENST00000421882.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr11_-_118135160 | 1.81 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero-like 2 |
| chr7_-_107443652 | 1.81 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
| chr3_+_130569592 | 1.80 |
ENST00000533801.2
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
| chr14_-_57272366 | 1.79 |
ENST00000554788.1
ENST00000554845.1 ENST00000408990.3 |
OTX2
|
orthodenticle homeobox 2 |
| chr12_-_53171128 | 1.77 |
ENST00000332411.2
|
KRT76
|
keratin 76 |
| chr18_+_61254570 | 1.77 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
| chr6_+_26199737 | 1.76 |
ENST00000359985.1
|
HIST1H2BF
|
histone cluster 1, H2bf |
| chr15_-_42264702 | 1.76 |
ENST00000220325.4
|
EHD4
|
EH-domain containing 4 |
| chr1_+_209878182 | 1.76 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr1_+_62439037 | 1.75 |
ENST00000545929.1
|
INADL
|
InaD-like (Drosophila) |
| chr1_+_63063152 | 1.73 |
ENST00000371129.3
|
ANGPTL3
|
angiopoietin-like 3 |
| chr19_-_51537982 | 1.72 |
ENST00000525263.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr15_+_40674920 | 1.71 |
ENST00000416151.2
ENST00000249776.8 |
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
| chr18_-_31803169 | 1.71 |
ENST00000590712.1
|
NOL4
|
nucleolar protein 4 |
| chr17_-_17184605 | 1.70 |
ENST00000268717.5
|
COPS3
|
COP9 signalosome subunit 3 |
| chr6_-_29055090 | 1.69 |
ENST00000377173.2
|
OR2B3
|
olfactory receptor, family 2, subfamily B, member 3 |
| chr3_+_182971018 | 1.69 |
ENST00000326505.3
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr11_-_107590383 | 1.67 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
| chr19_-_43708378 | 1.67 |
ENST00000599746.1
|
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr17_-_7307358 | 1.66 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr19_+_45409011 | 1.65 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr1_-_150780757 | 1.63 |
ENST00000271651.3
|
CTSK
|
cathepsin K |
| chr7_+_142458507 | 1.62 |
ENST00000492062.1
|
PRSS1
|
protease, serine, 1 (trypsin 1) |
| chr17_-_39254391 | 1.62 |
ENST00000333822.4
|
KRTAP4-8
|
keratin associated protein 4-8 |
| chr6_+_130339710 | 1.62 |
ENST00000526087.1
ENST00000533560.1 ENST00000361794.2 |
L3MBTL3
|
l(3)mbt-like 3 (Drosophila) |
| chr22_-_50523760 | 1.61 |
ENST00000395876.2
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
| chr6_+_106546808 | 1.60 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
| chr3_+_111630451 | 1.57 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
| chr21_-_31869451 | 1.55 |
ENST00000334058.2
|
KRTAP19-4
|
keratin associated protein 19-4 |
| chr11_+_12308447 | 1.53 |
ENST00000256186.2
|
MICALCL
|
MICAL C-terminal like |
| chr14_-_60097297 | 1.52 |
ENST00000395090.1
|
RTN1
|
reticulon 1 |
| chr10_-_95242044 | 1.51 |
ENST00000371501.4
ENST00000371502.4 ENST00000371489.1 |
MYOF
|
myoferlin |
| chr19_+_15838834 | 1.51 |
ENST00000305899.3
|
OR10H2
|
olfactory receptor, family 10, subfamily H, member 2 |
| chr13_+_32313658 | 1.49 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
| chr15_-_64665911 | 1.49 |
ENST00000606793.1
ENST00000561349.1 ENST00000560278.1 |
CTD-2116N17.1
|
Uncharacterized protein |
| chr6_+_106534192 | 1.48 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
| chr3_-_149093499 | 1.48 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr1_+_115572415 | 1.48 |
ENST00000256592.1
|
TSHB
|
thyroid stimulating hormone, beta |
| chr4_+_71200681 | 1.46 |
ENST00000273936.5
|
CABS1
|
calcium-binding protein, spermatid-specific 1 |
| chr3_+_189349162 | 1.46 |
ENST00000264731.3
ENST00000382063.4 ENST00000418709.2 ENST00000320472.5 ENST00000392460.3 ENST00000440651.2 |
TP63
|
tumor protein p63 |
| chr20_+_60174827 | 1.46 |
ENST00000543233.1
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal) |
| chr5_+_54320078 | 1.45 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr19_-_51538118 | 1.45 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr14_-_107283278 | 1.45 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
| chr7_+_13141097 | 1.45 |
ENST00000411542.1
|
AC011288.2
|
AC011288.2 |
| chr9_-_95244781 | 1.43 |
ENST00000375544.3
ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN
|
asporin |
| chr11_-_121986923 | 1.42 |
ENST00000560104.1
|
BLID
|
BH3-like motif containing, cell death inducer |
| chr9_+_116263778 | 1.42 |
ENST00000394646.3
|
RGS3
|
regulator of G-protein signaling 3 |
| chr4_+_71587669 | 1.42 |
ENST00000381006.3
ENST00000226328.4 |
RUFY3
|
RUN and FYVE domain containing 3 |
| chr11_+_72983246 | 1.42 |
ENST00000393590.2
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
| chr2_+_33359646 | 1.42 |
ENST00000390003.4
ENST00000418533.2 |
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr6_-_111927062 | 1.41 |
ENST00000359831.4
|
TRAF3IP2
|
TRAF3 interacting protein 2 |
| chr8_+_11666649 | 1.41 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
| chr14_-_60097524 | 1.41 |
ENST00000342503.4
|
RTN1
|
reticulon 1 |
| chr19_-_51538148 | 1.39 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
| chr5_-_125930929 | 1.36 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
| chrX_-_18690210 | 1.36 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
| chr7_+_77469439 | 1.36 |
ENST00000450574.1
ENST00000416283.2 ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
| chr3_-_149095652 | 1.36 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr10_-_14372870 | 1.34 |
ENST00000357447.2
|
FRMD4A
|
FERM domain containing 4A |
| chr1_+_50569575 | 1.34 |
ENST00000371827.1
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr14_-_24740709 | 1.34 |
ENST00000399409.3
ENST00000216840.6 |
RABGGTA
|
Rab geranylgeranyltransferase, alpha subunit |
| chr12_-_72057638 | 1.34 |
ENST00000552037.1
ENST00000378743.3 |
ZFC3H1
|
zinc finger, C3H1-type containing |
| chrX_+_49832231 | 1.34 |
ENST00000376108.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
| chr4_-_143226979 | 1.34 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
| chr15_+_40674963 | 1.32 |
ENST00000448395.2
|
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
| chr3_+_150126101 | 1.32 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
| chr4_-_39979576 | 1.31 |
ENST00000303538.8
ENST00000503396.1 |
PDS5A
|
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
| chr3_-_178984759 | 1.30 |
ENST00000349697.2
ENST00000497599.1 |
KCNMB3
|
potassium large conductance calcium-activated channel, subfamily M beta member 3 |
| chr7_+_129984630 | 1.30 |
ENST00000355388.3
ENST00000497503.1 ENST00000463587.1 ENST00000461828.1 ENST00000494311.1 ENST00000466363.2 ENST00000485477.1 ENST00000431780.2 ENST00000474905.1 |
CPA5
|
carboxypeptidase A5 |
| chr8_-_23712312 | 1.30 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
| chr6_+_29141311 | 1.29 |
ENST00000377167.2
|
OR2J2
|
olfactory receptor, family 2, subfamily J, member 2 |
| chr7_-_14026123 | 1.29 |
ENST00000420159.2
ENST00000399357.3 ENST00000403527.1 |
ETV1
|
ets variant 1 |
| chr4_+_144303093 | 1.27 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
| chr22_-_36357671 | 1.26 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr10_-_105110890 | 1.25 |
ENST00000369847.3
|
PCGF6
|
polycomb group ring finger 6 |
| chr2_-_166930131 | 1.25 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
| chr4_+_155484155 | 1.25 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
| chr2_+_204732666 | 1.25 |
ENST00000295854.6
ENST00000472206.1 |
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr12_+_72058130 | 1.24 |
ENST00000547843.1
|
THAP2
|
THAP domain containing, apoptosis associated protein 2 |
| chr10_-_29923893 | 1.24 |
ENST00000355867.4
|
SVIL
|
supervillin |
| chr4_+_41258786 | 1.24 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
| chr4_-_74853897 | 1.23 |
ENST00000296028.3
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
| chr1_+_44401479 | 1.22 |
ENST00000438616.3
|
ARTN
|
artemin |
| chr17_-_64225508 | 1.21 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr4_+_37828255 | 1.20 |
ENST00000381967.4
ENST00000544359.1 ENST00000537241.1 |
PGM2
|
phosphoglucomutase 2 |
| chr4_+_155484103 | 1.20 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
| chr4_+_169418255 | 1.20 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr4_+_86525299 | 1.19 |
ENST00000512201.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
| chr8_+_32579341 | 1.18 |
ENST00000519240.1
ENST00000539990.1 |
NRG1
|
neuregulin 1 |
| chr2_+_171034646 | 1.18 |
ENST00000409044.3
ENST00000408978.4 |
MYO3B
|
myosin IIIB |
| chr19_+_39687596 | 1.17 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr15_+_40675132 | 1.17 |
ENST00000608100.1
ENST00000557920.1 |
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
| chr1_-_89641680 | 1.17 |
ENST00000294671.2
|
GBP7
|
guanylate binding protein 7 |
| chrX_-_55057403 | 1.16 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
| chr7_-_14026063 | 1.16 |
ENST00000443608.1
ENST00000438956.1 |
ETV1
|
ets variant 1 |
| chr3_+_182971583 | 1.15 |
ENST00000460419.1
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| chr10_+_106034637 | 1.14 |
ENST00000401888.2
|
GSTO2
|
glutathione S-transferase omega 2 |
| chr17_-_10276319 | 1.14 |
ENST00000252172.4
ENST00000418404.3 |
MYH13
|
myosin, heavy chain 13, skeletal muscle |
| chr18_-_57027194 | 1.12 |
ENST00000251047.5
|
LMAN1
|
lectin, mannose-binding, 1 |
| chr18_+_55816546 | 1.12 |
ENST00000435432.2
ENST00000357895.5 ENST00000586263.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
| chr6_-_49604545 | 1.11 |
ENST00000371175.4
ENST00000229810.7 |
RHAG
|
Rh-associated glycoprotein |
| chr10_-_105110831 | 1.11 |
ENST00000337211.4
|
PCGF6
|
polycomb group ring finger 6 |
| chr13_-_38172863 | 1.09 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
| chr6_-_32157947 | 1.09 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr7_+_142031986 | 1.08 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chr17_+_66521936 | 1.07 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr2_+_204732487 | 1.07 |
ENST00000302823.3
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr11_+_65686802 | 1.06 |
ENST00000376991.2
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
| chr10_+_5238793 | 1.05 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
| chr4_-_152149033 | 1.04 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
| chr2_+_87808725 | 1.02 |
ENST00000413202.1
|
LINC00152
|
long intergenic non-protein coding RNA 152 |
| chr1_-_197036364 | 1.02 |
ENST00000367412.1
|
F13B
|
coagulation factor XIII, B polypeptide |
| chr1_-_205649580 | 1.01 |
ENST00000367145.3
|
SLC45A3
|
solute carrier family 45, member 3 |
| chr3_-_47934234 | 1.00 |
ENST00000420772.2
|
MAP4
|
microtubule-associated protein 4 |
| chr9_-_21351377 | 1.00 |
ENST00000380210.1
|
IFNA6
|
interferon, alpha 6 |
| chr2_-_172290482 | 1.00 |
ENST00000442541.1
ENST00000392599.2 ENST00000375258.4 |
METTL8
|
methyltransferase like 8 |
| chr1_+_44444865 | 0.99 |
ENST00000372324.1
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
| chr8_+_31496809 | 0.99 |
ENST00000518104.1
ENST00000519301.1 |
NRG1
|
neuregulin 1 |
| chr18_-_31803435 | 0.99 |
ENST00000589544.1
ENST00000269185.4 ENST00000261592.5 |
NOL4
|
nucleolar protein 4 |
| chr4_-_120243545 | 0.99 |
ENST00000274024.3
|
FABP2
|
fatty acid binding protein 2, intestinal |
| chr21_-_31859755 | 0.98 |
ENST00000334055.3
|
KRTAP19-2
|
keratin associated protein 19-2 |
| chr12_+_111374375 | 0.98 |
ENST00000553177.1
ENST00000548368.1 ENST00000331096.2 ENST00000547607.1 |
RP1-46F2.2
|
RP1-46F2.2 |
| chr1_+_155278539 | 0.98 |
ENST00000447866.1
|
FDPS
|
farnesyl diphosphate synthase |
| chr4_-_90756769 | 0.97 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
Network of associatons between targets according to the STRING database.
First level regulatory network of BARHL2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 4.7 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 1.6 | 4.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.4 | 4.2 | GO:0072034 | primary prostatic bud elongation(GO:0060516) renal vesicle induction(GO:0072034) |
| 1.0 | 3.8 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.9 | 2.8 | GO:1900082 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.8 | 0.8 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.8 | 2.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 | 4.4 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.7 | 4.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.7 | 3.5 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.6 | 1.9 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.6 | 3.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.6 | 4.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
| 0.6 | 3.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.6 | 1.7 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.6 | 1.7 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.6 | 1.7 | GO:2000646 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 3.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.5 | 2.0 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 | 2.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.5 | 1.4 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 1.2 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.4 | 3.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.4 | 1.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.4 | 1.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.4 | 5.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 | 1.1 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.4 | 2.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.4 | 1.4 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.3 | 2.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 1.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.3 | 9.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 2.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.3 | 1.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 | 4.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.3 | 2.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.3 | 0.9 | GO:0032900 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of neurotrophin production(GO:0032900) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 4.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 2.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 | 1.4 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.3 | 1.1 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.3 | 2.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.3 | 2.1 | GO:0032914 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.3 | 1.9 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.3 | 0.8 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.3 | 1.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 | 1.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.3 | 2.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 2.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.2 | 1.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 1.0 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 0.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.2 | 1.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.2 | 4.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 | 2.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 0.6 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.2 | 0.6 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.2 | 1.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.6 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.2 | 1.0 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.2 | 1.0 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 | 4.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.2 | 0.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 | 1.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 1.7 | GO:0051005 | negative regulation of phospholipase activity(GO:0010519) negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 1.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 | 2.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 1.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 2.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 1.0 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.8 | GO:0030070 | insulin processing(GO:0030070) |
| 0.2 | 2.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 9.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.2 | 1.1 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 1.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 4.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 2.2 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 1.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 0.4 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 1.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.4 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 | 18.0 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 1.0 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 0.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.1 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 1.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.1 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 | 2.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 1.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.1 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 | 0.6 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.1 | 1.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 0.4 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.1 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 1.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 0.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 1.1 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 0.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.1 | 1.0 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 7.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 1.4 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.3 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 3.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.3 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.1 | 1.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.8 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 1.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.1 | 4.7 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.2 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 0.1 | 1.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 1.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 5.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 2.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 1.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 1.9 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 1.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 2.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 1.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 | 1.8 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 1.5 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 4.7 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 1.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 1.5 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 2.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 1.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 1.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 2.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 4.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 | 0.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 | 0.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.0 | 0.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.1 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.0 | 2.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.0 | 0.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
| 0.0 | 1.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 | 0.3 | GO:0002857 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 | 0.6 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 | 0.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 | 1.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 4.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 1.2 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.0 | 0.4 | GO:2000507 | cap-dependent translational initiation(GO:0002191) positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 2.5 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 1.5 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 2.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.4 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
| 0.0 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 | 0.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 | 3.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 2.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.0 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.0 | 0.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 1.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.0 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.5 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.0 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 | 5.9 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.0 | 2.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.5 | GO:0001501 | skeletal system development(GO:0001501) |
| 0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 1.9 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 1.3 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 4.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.0 | 3.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 1.8 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 1.0 | GO:0008283 | cell proliferation(GO:0008283) |
| 0.0 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.2 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
| 0.0 | 0.4 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.2 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.0 | 0.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 0.6 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.6 | GO:0009409 | response to cold(GO:0009409) |
| 0.0 | 0.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
| 0.0 | 0.1 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 3.3 | GO:0009408 | response to heat(GO:0009408) |
| 0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.6 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 1.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 1.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.0 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.1 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 | 0.1 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
| 0.0 | 0.4 | GO:1990748 | detoxification(GO:0098754) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.0 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.0 | 0.4 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
| 0.0 | 0.4 | GO:0002520 | immune system development(GO:0002520) hemopoiesis(GO:0030097) hematopoietic or lymphoid organ development(GO:0048534) |
| 0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 1.0 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 1.3 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.4 | GO:0007140 | male meiosis(GO:0007140) |
| 0.0 | 0.4 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
| 0.0 | 0.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 0.0 | 0.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 9.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.1 | 3.3 | GO:0031523 | Myb complex(GO:0031523) |
| 1.0 | 3.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.6 | 8.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 2.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.6 | 1.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.4 | 2.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.4 | 4.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 3.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 2.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 0.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 2.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 0.5 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 4.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 3.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 2.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 0.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 4.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 2.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 5.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 1.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 2.2 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.4 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 4.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 3.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 1.8 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 1.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 2.1 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 1.0 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 3.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 13.6 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 2.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 1.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 4.2 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 2.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 5.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 4.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.0 | 1.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 1.3 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 2.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
| 0.0 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 1.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.0 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 23.8 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 2.6 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 5.1 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 3.7 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 2.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 2.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 4.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 3.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 2.3 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 1.1 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 1.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 1.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.4 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 2.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 2.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.0 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 6.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 3.8 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.9 | 2.8 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.9 | 2.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.8 | 3.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.8 | 4.6 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.7 | 4.4 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.7 | 2.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.6 | 10.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.6 | 1.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.4 | 1.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.4 | 1.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.4 | 4.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.4 | 1.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 1.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.4 | 1.4 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 1.0 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.3 | 5.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 1.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.3 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.3 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 1.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 1.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.3 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.3 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 1.0 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 1.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 0.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 3.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 1.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.2 | 1.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.2 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.2 | 2.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 0.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.2 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 1.0 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 1.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.2 | 4.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 1.1 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.2 | 0.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.2 | 2.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 1.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 4.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 5.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.4 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 3.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 3.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 2.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 2.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 3.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.1 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 15.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 1.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 1.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 1.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 0.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 3.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 1.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 0.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.3 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 1.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 2.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 1.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 2.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 4.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 3.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.2 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.0 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 2.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 2.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.2 | GO:0044388 | ubiquitin activating enzyme activity(GO:0004839) small protein activating enzyme binding(GO:0044388) |
| 0.0 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.0 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 1.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 4.4 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 4.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 2.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.8 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
| 0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.0 | 8.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.1 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 1.7 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 2.2 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 3.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.0 | 2.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 1.9 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 5.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 4.4 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 1.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 9.0 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 1.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 4.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 2.8 | GO:0008017 | microtubule binding(GO:0008017) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 9.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 13.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 4.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 3.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 4.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 4.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 5.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 6.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 2.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 2.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 8.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 2.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.0 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 3.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 1.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 2.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 3.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.3 | 4.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 5.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 5.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 3.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 4.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 13.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 6.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 4.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 4.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 5.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 4.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 3.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 11.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 4.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 1.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 3.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 2.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 2.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 2.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 2.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 2.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 3.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 3.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 1.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 0.7 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 3.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 4.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.0 | 1.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 2.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 1.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 1.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 3.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 1.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 1.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 1.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 2.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 2.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |